Summit Partners Public Asset Management’s Guardant Health GH Stock Holding History

Summit Partners Public Asset Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$79.7M	Buy	862,915 +10,957	+1%	+$1.1M	2.14%	10
2025 Q4	$87M	Buy	851,958 +741,958	+675%	+$66.4M	1.81%	17
2025 Q3	$6.87M	Buy	+110,000	New	+$5.98M	0.14%	114
2021 Q1	–	Sell	-79,532	Closed	-$10.3M	–	104
2020 Q4	$10.3M	Sell	79,532 -285	-0.4%	-$32.8K	0.46%	63
2020 Q3	$8.92M	Sell	79,817 -168,896	-68%	-$15.5M	0.45%	62
2020 Q2	$20.2M	Buy	248,713 +56,300	+29%	+$4.54M	1.21%	26
2020 Q1	$13.4M	Sell	192,413 -87,587	-31%	-$6.72M	1.1%	31
2019 Q4	$21.9M	Buy	280,000 +109,931	+65%	+$7.92M	2.07%	15
2019 Q3	$10.9M	Buy	170,069 +100,071	+143%	+$8.82M	1.07%	38
2019 Q2	$6.04M	Buy	+69,998	New	+$5.35M	0.6%	64

Other funds holding GH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Summit Partners Public Asset Management's GH Position: Q1 2026 in Review

Summit Partners Public Asset Management increased its Guardant Health (GH) stake by 1.3% in Q1 2026, buying an estimated $1.1M and bringing the position to 862,915 shares worth $79.7M. The position accounts for 2.14% of the portfolio, ranked #10.

Summit Partners Public Asset Management first reported a position in GH in Q2 2019 and has held it in 10 quarters since. The position peaked at $87M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

Summit Partners Public Asset Management held 862,915 shares of Guardant Health worth $79.7M as of Q1 2026.
Summit Partners Public Asset Management bought 10,957 Guardant Health shares in Q1 2026, an estimated $1.1M.
Guardant Health made up 2.14% of Summit Partners Public Asset Management's portfolio in Q1 2026, its #10 holding.
Summit Partners Public Asset Management first reported a position in Guardant Health in Q2 2019 and has held it in 10 quarters since.
Summit Partners Public Asset Management's Guardant Health position peaked at $87M in Q4 2025.
481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Summit Partners Public Asset Management's 13F filing for Q1 2026, filed 15 May 2026.